← Back to Search

COVID-19 Group Problem Solving plus Standard of Care for COVID-19

N/A
Waitlist Available
Led By Maria E Fernandez-Esquer, PhD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 4 weeks post intervention
Awards & highlights

Study Summary

The purpose of this study is to adapt and pilot test the feasibility of implementing a corner-based risk reduction program that aims to assist Latino day laborers (LDL) in their efforts to adhere to COVID-19 mitigation practices, including receiving the COVID-19 vaccine, using personal protective equipment (PPE), and practicing social distancing.

Eligible Conditions
  • COVID-19
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4 weeks post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4 weeks post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants With Change in COVID-19 Vaccination Status Assessed by a Survey
Secondary outcome measures
Change in Mask Wearing Frequency as Assessed by Change in Mean Mask Use Total Score on a Survey
Change in Social Distancing as Assessed by Change in Mean Social Distancing Total Score on a Survey

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: COVID-19 Group Problem Solving plus Standard of CareExperimental Treatment2 Interventions
Group II: Standard of CareActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
COVID-19 Group Problem Solving
2023
N/A
~560
Standard of Care
2017
Completed Phase 4
~4420

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
904 Previous Clinical Trials
320,760 Total Patients Enrolled
6 Trials studying COVID-19
10,309 Patients Enrolled for COVID-19
National Institute on Minority Health and Health Disparities (NIMHD)NIH
383 Previous Clinical Trials
1,216,011 Total Patients Enrolled
18 Trials studying COVID-19
157,099 Patients Enrolled for COVID-19
Maria E Fernandez-Esquer, PhDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
1 Previous Clinical Trials
359 Total Patients Enrolled
1 Trials studying COVID-19
359 Patients Enrolled for COVID-19

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Vale+ Tu Salud: Corner-Based Randomized Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19
Maria Eugenia Fernandez-Esquer 2022. "Vale+ Tu Salud: Corner-Based Randomized Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05248399.
~65 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top